| 1 | [SID49823586] | Active | Potency | 3.6626 | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. [AID624296, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. | | AID | 624296 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 2 | [SID49823586] | Active | EC50 | 4.02 | Dose response counterscreen for uHTS small molecule activators of the adaptive arm of the Unfolded Protein Response via a luminescent-based reporter assay [AID489027, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | EC50 | 4.02 [uM] | | BioAssay | Dose response counterscreen for uHTS small molecule activators of the adaptive arm of the Unfolded Protein Response via a luminescent-based reporter assay | | AID | 489027 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID49823586] | Active | IC50 | 4.94 | uHTS Homogeneous Terbium Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay [AID2091, Type: confirmatory] | Mint1 [Rattus norvegicus] [gi:2625023] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | IC50 | 4.94 [uM] | | BioAssay | uHTS Homogeneous Terbium Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay | | AID | 2091 | | BioAssay type | confirmatory | | Target | Mint1 [Rattus norvegicus] [gi:2625023] | | PubMed | | | Data Table |  |
|
| 4 | [SID49823586] | Active | EC50 | 5.37 | Dose response confirmation of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay [AID489024, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | EC50 | 5.37 [uM] | | BioAssay | Dose response confirmation of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay | | AID | 489024 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID49823586] | Active | Potency | 10 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 6 | [SID49823586] | Active | Potency | 10 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 7 | [SID49823586] | Active | Potency | 10 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 8 | [SID49823586] | Active | Potency | 10 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 9 | [SID49823586] | Active | Potency | 10 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 10 | [SID49823586] | Active | Potency | 10 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 11 | [SID49823586] | Active | Potency | 10 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID49823586] | Active | Potency | 11.5821 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 13 | [SID49823586] | Active | Potency | 11.5821 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 14 | [SID49823586] | Active | Potency | 11.5821 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 15 | [SID49823586] | Active | Potency | 14.581 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 16 | [SID49823586] | Active | Potency | 14.581 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 17 | [SID49823586] | Active | Potency | 14.581 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 18 | [SID49823586] | Active | IC50 | 15.2 | Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay [AID2073, Type: confirmatory] | Mint1 [Rattus norvegicus] [gi:2625023] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | IC50 | 15.2 [uM] | | BioAssay | Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay | | AID | 2073 | | BioAssay type | confirmatory | | Target | Mint1 [Rattus norvegicus] [gi:2625023] | | PubMed | | | Data Table |  |
|
| 19 | [SID49823586] | Active | IC50 | 18 | Dose response confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay [AID624317, Type: confirmatory] | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | IC50 | 18 [uM] | | BioAssay | Dose response confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay | | AID | 624317 | | BioAssay type | confirmatory | | Target | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] | | PubMed | | | Data Table |  |
|
| 20 | [SID49823586] | Active | Potency | 22.3872 | qHTS for Inhibitors of WRN Helicase [AID651768, Type: confirmatory] | WRN [Homo sapiens] [gi:3719421] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS for Inhibitors of WRN Helicase | | AID | 651768 | | BioAssay type | confirmatory | | Target | WRN [Homo sapiens] [gi:3719421] | | PubMed | | | Data Table |  |
|
| 21 | [SID49823586] | Active | Potency | 25.1189 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 22 | [SID49823586] | Active | Potency | 31.6228 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 23 | [SID49823586] | Active | IC50 | 37.3 | Dose response confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay - Set 2 [AID651709, Type: confirmatory] | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | IC50 | 37.3 [uM] | | BioAssay | Dose response confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay - Set 2 | | AID | 651709 | | BioAssay type | confirmatory | | Target | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] | | PubMed | | | Data Table |  |
|
| 24 | [SID49823586] | Active | Potency | 39.8107 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 25 | [SID49823586] | Active | Potency | 44.6684 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 26 | [SID49823586] | Active | Potency | 50.1187 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 27 | [SID49823586] | Active | Potency | 50.1187 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 28 | [SID49823586] | Active | Potency | 56.2341 | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). [AID588795, Type: confirmatory] | flap endonuclease 1 [Homo sapiens] [gi:4758356] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | Potency | 56.2341 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). | | AID | 588795 | | BioAssay type | confirmatory | | Target | flap endonuclease 1 [Homo sapiens] [gi:4758356] | | PubMed | | | Data Table |  |
|
| 29 | [SID49823586] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists [AID624463, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists | | AID | 624463 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 30 | [SID49823586] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists [AID624463, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists | | AID | 624463 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 31 | [SID49823586] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists [AID624463, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists | | AID | 624463 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 32 | [SID49823586] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists [AID624463, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists | | AID | 624463 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 33 | [SID49823586] | Active | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists [AID624463, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists | | AID | 624463 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 34 | [SID49823586] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 35 | [SID49823586] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 36 | [SID49823586] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 37 | [SID49823586] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2168, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2168 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 38 | [SID49823586] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2168, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2168 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 39 | [SID49823586] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2168, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2168 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 40 | [SID49823586] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 41 | [SID49823586] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 42 | [SID49823586] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2129, Type: screening] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2129 | | BioAssay type | screening | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 43 | [SID49823586] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2129, Type: screening] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2129 | | BioAssay type | screening | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 44 | [SID49823586] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2129, Type: screening] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2129 | | BioAssay type | screening | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 45 | [SID49823586] | Active | | | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2166, Type: screening] | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | BioAssay | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2166 | | BioAssay type | screening | | Target | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] | | PubMed | | | Data Table |  |
|
| 46 | [SID49823586] | Active | | | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2166, Type: screening] | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | BioAssay | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2166 | | BioAssay type | screening | | Target | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] | | PubMed | | | Data Table |  |
|
| 47 | [SID49823586] | Active | | | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2166, Type: screening] | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | BioAssay | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2166 | | BioAssay type | screening | | Target | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] | | PubMed | | | Data Table |  |
|
| 48 | [SID49823586] | Active | | | Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3) [AID1800, Type: screening] | NS3 [Hepatitis C virus] [gi:125541954] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | BioAssay | Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3) | | AID | 1800 | | BioAssay type | screening | | Target | NS3 [Hepatitis C virus] [gi:125541954] | | PubMed | | | Data Table |  |
|
| 49 | [SID49823586] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats [AID651821, Type: screening] | |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats | | AID | 651821 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 50 | [SID49823586] | Active | | | Fluorescence-based biochemical high throughput confirmation assay to identify molecules that bind r(CAG) RNA repeats [AID652065, Type: screening] | |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49823586 | | CID | 25237246 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput confirmation assay to identify molecules that bind r(CAG) RNA repeats | | AID | 652065 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|